Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.
An Illinois federal judge has entered judgment in favor of AbbVie and other makers of testosterone replacement drugs in a Racketeer Influenced and Corrupt Organizations Act suit brought by an insurer, saying there was no evidence the insurer was misled by the companies.
Boston Scientific Corp. revealed Friday that the Federal Trade Commission has asked for more info about its planned £3.3 billion ($4.2 billion) purchase of U.K.-based BTG PLC, saying the government is focused on certain types of tumor treatments sold by both companies.
An Akorn Inc. investor told an Illinois federal court the pharmaceutical company's executives should not be able to dodge a suit alleging they lied in public statements for their own benefit, concealed regulatory problems and sunk a major merger deal with their inept behavior.
McDermott Will & Emery LLP has hired a former U.S. Food and Drug Administration attorney as an addition to the firm’s practice in Washington, D.C., saying she will help expand the firm's life sciences breadth.
Pillsbury Winthrop Shaw Pittman LLP has added a former Vinson & Elkins LLP commercial litigator to its New York City office as a partner.